Information last reviewed: May 2026 — for educational purposes only.
Ezetimibe, sold as Zetia, is a prescription cholesterol-lowering drug that works by a completely different mechanism from statins. Rather than inhibiting cholesterol synthesis in the liver, ezetimibe selectively inhibits the NPC1L1 transporter in the brush border of small intestinal enterocytes, blocking the absorption of both dietary and biliary cholesterol from the gut. This typically reduces LDL cholesterol by 15–20% as monotherapy, and provides an additional 15–20% LDL reduction in patients already on a statin — making it a valuable add-on for patients who need further LDL lowering.
What Is Ezetimibe (Zetia) Used For?
- Primary hypercholesterolaemia — as monotherapy or combined with a statin
- Homozygous familial hypercholesterolaemia (HoFH) — combined with atorvastatin or simvastatin
- Homozygous sitosterolaemia (phytosterolaemia) — a rare inherited disorder causing increased plant sterol absorption
The landmark IMPROVE-IT trial (2015) randomised over 18,000 post-ACS patients to simvastatin + ezetimibe vs. simvastatin + placebo. The combined therapy achieved greater LDL reduction and demonstrated a modest but statistically significant reduction in cardiovascular events, validating the LDL hypothesis and the benefit of adding ezetimibe to a statin in high-risk patients.
Is Ezetimibe Available Without a Prescription?
No. Ezetimibe is prescription-only in all major markets. It is available as the standalone Zetia brand, as generic ezetimibe tablets, and in combination products: Vytorin (ezetimibe 10 mg + simvastatin 10/20/40/80 mg) and as part of combined packs with atorvastatin in some countries.
Strength and Dosing
- Ezetimibe 10 mg tablet — the only oral dose available; taken once daily at any time of day, with or without food; can be taken at the same time as a statin or at a different time
- IMPORTANT: Bile acid sequestrants (cholestyramine, colestipol) reduce ezetimibe absorption by up to 55% — take ezetimibe at least 2 hours before or 4 hours after a bile acid sequestrant
- Combination product: Vytorin 10/10, 10/20, 10/40, 10/80 (ezetimibe 10 mg + simvastatin 10/20/40/80 mg) — note 10/80 formulation dose-restricted like plain simvastatin 80 mg
Price of Generic Ezetimibe
Generic ezetimibe became available in the US in 2017 and is now widely affordable. A 30-day supply costs approximately $15–$30 with a discount card. Brand-name Zetia is significantly more expensive.
Frequently Asked Questions
How is ezetimibe different from statins?
Statins reduce cholesterol by inhibiting its synthesis in the liver, while ezetimibe blocks absorption of cholesterol in the small intestine. The mechanisms complement each other — when cholesterol absorption is reduced, the liver compensates by producing more cholesterol; when synthesis is reduced by a statin, more cholesterol is absorbed from the gut. Combining both addresses both pathways for enhanced LDL reduction. Ezetimibe does not share the muscle-related side effects of statins.
Can ezetimibe be used if I cannot tolerate statins?
Yes. Ezetimibe has a very favourable side effect profile and is well-tolerated by the vast majority of patients, including those with statin intolerance (myalgia). As monotherapy it provides a 15–20% LDL reduction — less than a statin but still clinically meaningful. It can be a valuable option for statin-intolerant patients, though the degree of LDL lowering achievable may require supplementation with other non-statin agents (e.g., PCSK9 inhibitors) in high-risk patients.
How quickly does ezetimibe reduce LDL cholesterol?
Ezetimibe begins reducing LDL relatively quickly. A significant reduction is typically visible within 2–4 weeks of initiating therapy. Full steady-state effect is reached within 2 weeks. Lipid panels are usually checked 4–6 weeks after starting or changing dose.
Disclaimer: This page is for general informational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional before taking any medication. See our full disclaimer.